<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transformation in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> represents an abrupt transition in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biology </plain></SENT>
<SENT sid="1" pm="."><plain>The protein product of the bcl-2 oncogene is overexpressed in most follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and inhibits <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>The protein product of the p53 oncogene prevents cell proliferation and induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and is overexpressed in the dysfunctional (mutated) form </plain></SENT>
<SENT sid="3" pm="."><plain>We studied 15 transformed <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (large cell type), 7 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> before transformation and 2 control groups of follicular center cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with no evidence of transformation (9 small cleaved cell and 10 de novo large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>) </plain></SENT>
<SENT sid="4" pm="."><plain>High p53 expression (&gt; or = 45% cells) was detected by immunostaining in 9/15 transformed <z:hpo ids='HP_0002665'>lymphomas</z:hpo> as compared with 0/10 de novo large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and 1/7 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Overexpression of bcl-2 (&gt; or = 50% cells) was similar in transformed (11/15) and de novo large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (6/10) </plain></SENT>
<SENT sid="6" pm="."><plain>The apoptotic index was high (&gt; or = 2%) in <z:hpo ids='HP_0000001'>all</z:hpo> transformed and large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and low in <z:hpo ids='HP_0000001'>all</z:hpo> follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and in the control group of small cleaved cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The apoptotic index in the transformed <z:hpo ids='HP_0002665'>lymphomas</z:hpo> appeared to be independent of bcl-2 expression and was sometimes paradoxically high in the presence of both p53 and bcl-2 overexpression </plain></SENT>
<SENT sid="8" pm="."><plain>The apoptotic index was weakly associated with bcl-2 expression in de novo large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Expression of p53 did not correlate with proliferation index </plain></SENT>
<SENT sid="10" pm="."><plain>Our results indicate that p53 overexpression is a specific step associated with transformation and may occur shortly before it </plain></SENT>
<SENT sid="11" pm="."><plain>This is not seen in de novo large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Furthermore, the high apoptotic index in transformed <z:hpo ids='HP_0002665'>lymphomas</z:hpo> often occurs despite overexpression of bcl-2 and p53, implying that other factors may induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>